The Application, Challenges, and Advancement Toward Regulatory Acceptance of Digital Toxicologic Pathology: Results of the 7th ESTP International Expert Workshop (September 20-21, 2019)

Author:

Schumacher Vanessa L.1ORCID,Aeffner Famke2ORCID,Barale-Thomas Erio3ORCID,Botteron Catherine4,Carter Jonathan5,Elies Laëtitia67,Engelhardt Jeffery A.8ORCID,Fant Pierluigi7,Forest Thomas9,Hall Peter10ORCID,Hildebrand Deon11,Klopfleisch Robert12,Lucotte Thomas13,Marxfeld Heike14ORCID,Mckinney LuAnn15,Moulin Pierre16ORCID,Neyens Elizabeth17ORCID,Palazzi Xavier18,Piton Alain19,Riccardi Elena20,Roth Daniel R.21,Rousselle Serge22ORCID,Vidal Justin D.23,Williams Bethany2425

Affiliation:

1. Roche Innovation Center Basel, Pharma Research and Early Development, F. Hoffmann-La Roche, Ltd, Basel, Switzerland

2. Amgen Inc, Amgen Research, Translational Safety and Bioanalytical Sciences, South San Francisco, CA, USA

3. Janssen R&D, Beerse, Belgium

4. Sirius Pathology, Cruseilles, France

5. Covance Laboratories, Harrogate, United Kingdom

6. Bayer Crop Science Division, Sophia Antipolis, France

7. Charles River Laboratories, Lyon, France

8. Ionis Pharmaceuticals Inc, Carlsbad, CA, USA

9. Merck & Co, Inc, West Point, Pennsylvania, USA

10. UCB Pharma, Slough, United Kingdom

11. GlaxoSmithKline, Ware, United Kingdom

12. Freie Universitaet Berlin, Institute of Veterinary Pathology, Berlin, Germany

13. Agence nationale de sécurité du médicament et des produits de santé (ANSM), Saint-Denis, France

14. BASF SE, Ludwigshafen, Germany

15. US Food and Drug Administration, Silver Spring, MD, USA

16. Novartis, Basel, Switzerland

17. Elizabethtoxpath Consulting Inc, Vancouver, British Columbia, Canada

18. Pfizer, Groton, CT, USA

19. ALP Quality Systems, Sophia Antipolis, France

20. IDEXX Laboratories Ltd, Wetherby, United Kingdom

21. Swissmedic, Bern, Switzerland

22. StageBio, Thurmont, MD, USA

23. Charles River, Mattawan, MI, USA

24. Department of Histopathology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

25. Faculty of Medicine and Health, University of Leeds, Leeds, United Kingdom

Abstract

With advancements in whole slide imaging technology and improved understanding of the features of pathologist workstations required for digital slide evaluation, many institutions are investigating broad digital pathology adoption. The benefits of digital pathology evaluation include remote access to study or diagnostic case materials and integration of analysis and reporting tools. Diagnosis based on whole slide images is established in human medical pathology, and the use of digital pathology in toxicologic pathology is increasing. However, there has not been broad adoption in toxicologic pathology, particularly in the context of regulatory studies, due to lack of precedence. To address this topic, as well as practical aspects, the European Society of Toxicologic Pathology coordinated an expert international workshop to assess current applications and challenges and outline a set of minimal requirements needed to gain future regulatory acceptance for the use of digital toxicologic pathology workflows in research and development, so that toxicologic pathologists can benefit from digital slide technology.

Publisher

SAGE Publications

Subject

Cell Biology,Toxicology,Molecular Biology,Pathology and Forensic Medicine

Reference64 articles.

1. The Pathologist 2.0: An Update on Digital Pathology in Veterinary Medicine

2. Toxicologic Pathology Forum*: Opinion on Considerations for the Use of Whole Slide Images in GLP Pathology Peer Review

3. Center for Devices and Radiological Health. Technical Performance Assessment of Digital Pathology Whole Slide Imaging Devices. Guidance for industry and food and drug administration staff. Published 2016. Accessed November 23, 2020. https://www.fda.gov/media/90791/download

4. Toxicologic Pathology Forum*: Opinion on Integrating Innovative Digital Pathology Tools in the Regulatory Framework

5. Utilizing Whole Slide Images for Pathology Peer Review and Working Groups

Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3